Home » Topics » BioWorld Science

BioWorld Science
RSS

Cypress Bioscience/PRP merger imminent

Aug. 30, 1996

Celox Laboratories' ViaStem covered under patent

Aug. 30, 1996

DNX Corporation and BioClin International to merge

Aug. 30, 1996

Medtronic acquires catheter product line

Aug. 30, 1996

Activated Cell Therapy's cell processing devices earn FDA approval

Aug. 30, 1996

Zyn-Linker shows promising results in preclinicals

Aug. 30, 1996

CGP-25454 tested in healthy volunteers

Aug. 30, 1996

Correlation established between serum PLA2 activity and schizophrenia symptoms

Aug. 30, 1996

Potential antipsychotic described by Parke-Davis

Aug. 30, 1996

Famotidine tested in schizophrenic patients

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...